| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 03/21/2007 | CN1305894C Process for extracting total saponin of American ginseng and powder injection thereof |
| 03/15/2007 | US20070059752 Fluorescence energy transfer probes with stabilized conformations |
| 02/28/2007 | EP1756140A1 Selective separation or extraction of steroidal glycosides by supercritical fluid extraction using carbon dioxide |
| 02/22/2007 | US20070042939 Hepatitis C; antivirals; 8-modified,1', 2', 3' or 4'-branched purine nucleoside; treating HCV infection |
| 02/15/2007 | US20070037735 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/14/2007 | EP1539796B1 Anti-inflammatory or anti-allergic androstane complexes |
| 02/01/2007 | US20070027128 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour |
| 01/24/2007 | EP1745060A2 Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production |
| 01/23/2007 | US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction |
| 01/18/2007 | WO2007006208A1 Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 01/10/2007 | CN1294142C 17 beta-carbothioate 17 alpha-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 01/10/2007 | CN1294141C 6 alpha., 9 alpha-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 01/09/2007 | US7160866 Isolation of tigogenin pentaglycoside from Chlorophytum nimonii |
| 01/09/2007 | US7160733 Ligand specific to β2-glycoprotein I and use thereof |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 12/19/2006 | CA2149496C 11,21-bisphenyl-19-norpregnane derivatives |
| 12/13/2006 | EP1731527A1 Glycoside having 4-methylergost-7-en-3-ol skeleton and drug for ameliorating hyperglycemia |
| 12/05/2006 | US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 11/30/2006 | US20060269926 Novel dyes for the detection or quantification of desirable target molecules |
| 11/23/2006 | WO2006123464A1 Drugs, food or drink for improving pancreatic functions |
| 11/14/2006 | CA2258681C Process for the preparation of 17-esters of 9.alpha.,21-dihalo-pregnane-11.beta.,17.alpha.diol-20-ones |
| 11/09/2006 | US20060252704 Bevirimat dimeglumine (DSB*2NMG) crystal forms; HIV |
| 11/07/2006 | US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 11/02/2006 | EP0973534B1 Plant extracts having appetite suppressant activity |
| 10/26/2006 | WO2006113495A2 Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof |
| 10/26/2006 | US20060240129 Skin tissue regeneration promoters comprising ginsenoside Rb1 |
| 10/25/2006 | CN1852918A Methods and compositions for interferon therapy |
| 10/24/2006 | US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 10/24/2006 | US7125975 Derivatized oligonucleotides having improved uptake and other properties |
| 10/19/2006 | WO2006110810A2 Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine |
| 10/19/2006 | US20060234956 Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof |
| 10/17/2006 | US7122649 Derivatized oligonucleotides having improved uptake and other properties |
| 10/12/2006 | US20060228430 Novel method for preparing processed ginseng to obtain increased amount of ginsenoside RG5 |
| 10/11/2006 | EP1471896B1 Formulations for inhalation |
| 10/11/2006 | EP0894000B1 Use for delivering estrogen |
| 10/11/2006 | CN1845932A Transfection agents |
| 10/11/2006 | CN1279052C Process for extracting total flavone and total oside of astragalus from astragalus |
| 10/10/2006 | US7119082 11β-long-chain-substituted 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring |
| 10/04/2006 | CN1842536A Glycoside having 4-methylergost-7-en-3-ol skeleton and drug for ameliorating hyperglycemia |
| 10/04/2006 | CN1840539A Salangane saponin and preparation method and use thereof |
| 09/28/2006 | US20060217293 Coupling low-molecular substances to a modified polysaccharide |
| 09/21/2006 | US20060211857 6,7-Oxygenated steroids and uses related thereto |
| 09/20/2006 | CN1834105A First 22-ketal steroid compound, synthetic process and applications |
| 09/14/2006 | US20060205931 Pharmaceutical compositions having appetite suppressant activity |
| 09/14/2006 | US20060204515 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 09/05/2006 | US7101866 6,9-Difluoro-17 alpha -((2-furanylcarbonyl)oxy)-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; antiinflammatory agents for the treatment of allergic conditions |
| 08/31/2006 | US20060193903 hydrophobic drug having (a) glycoside like GlcNAc-Gal-, GlcNAc-Gal-Glc-, Fuc-Gal- as sugar moiety (b) phosphatidylcholines (c) stearylamine/oleylamine; composition improves the low solubility of gylcoside; cholestenol/ ceramide/naphthalene-2-methanol -glycoside anticancer drug; improved drug delivery |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/24/2006 | US20060189550 Immunostimulatory, Covalently lipidated oligonucleotides |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/23/2006 | CN1822844A Glycoside-containing liposome |
| 08/22/2006 | CA2328085C Solid dispersion containing sialic acid derivative |
| 08/17/2006 | WO2006086377A2 Method of detection of classical swine fever |
| 08/17/2006 | US20060183696 Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract |
| 08/17/2006 | CA2597383A1 Method of detection of classical swine fever |
| 08/16/2006 | CN1269836C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 08/10/2006 | US20060177818 Multiplex real-time RT-PCR assay with a heterologous internal control system; could be performed as a one-tube assay without loss of sensitivity or specificity |
| 08/08/2006 | US7087590 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 08/03/2006 | US20060172309 5-methylcytosine detection, compositions and methods therefor |
| 08/03/2006 | US20060172308 Labeling reagents and labeled targets comprising nonmetallic porphyrins |
| 07/27/2006 | US20060166903 Phosphocholine linked prodrug derivatives |
| 07/26/2006 | EP1082338B1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/20/2006 | US20060160752 Promoter for the production of hyaluronic acid containing ginsenoside compound k |
| 07/19/2006 | EP1082337B1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/13/2006 | DE19713768B4 Herstellung von Betulinsäure Production of betulinic |
| 07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/06/2006 | US20060149045 Steroid compounds with anti-tumor activity |
| 07/06/2006 | US20060148773 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; benign prostatic hyperplasa; cardiovascular disorders; acne |
| 07/05/2006 | CN1262560C 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds |
| 06/27/2006 | US7067682 6,7-Oxygenated steroids and uses related thereto |
| 06/15/2006 | WO2006019685A3 Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production |
| 06/15/2006 | US20060128950 Glucuronide metabolites and epimers thereof of tigecycline |
| 06/15/2006 | US20060128639 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 06/14/2006 | EP1669078A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside RB 1 |
| 06/14/2006 | CN1259365C High friction coefficient rubber composite brake shoes |
| 06/08/2006 | US20060122382 Method of manufacturing labelled oligonucleotide conjugates |
| 06/01/2006 | US20060116331 Glycosylceramide analogues |
| 05/23/2006 | US7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 05/18/2006 | WO2006052717A2 Glucuronide metabolites and epimers thereof of tigecycline |
| 05/18/2006 | CA2586245A1 Glucuronide metabolites and epimers thereof of tigecycline |
| 05/17/2006 | CN1774444A Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 05/09/2006 | US7041839 Therapy for hormone sensitivity disease; side effect reduction; anticancer agents |
| 05/04/2006 | WO2006045171A2 Process for obtaining dry steroids derivative from ergostane |
| 05/04/2006 | US20060094664 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 05/03/2006 | CN1767828A Medicinal composition |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 04/26/2006 | CN1763069A Gen-seng saponin Rg2 preparation method, its pharmaceutical composition and uses in pharmacy |
| 04/19/2006 | EP1647277A1 Glycoside-containing liposome |
| 04/12/2006 | CN1250563C Androgen glycosides and androgenic activity thereof |
| 03/30/2006 | US20060069043 Chiral separation, characterization and biological action of optically active isomers of digoxin |
| 03/29/2006 | CN1752095A C27-steroid antitumour medicine |
| 03/28/2006 | US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/21/2006 | CA2062792C Treatment of androgen-related diseases |
| 03/08/2006 | EP1423407B1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 03/01/2006 | CN1243767C Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 02/23/2006 | WO2006019685A2 Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production |
| 02/23/2006 | US20060041109 Neoglycorandomization and digitoxin analogs |
| 02/23/2006 | CA2573699A1 Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production |
| 02/22/2006 | EP1028734B1 Use of specific steady-state r-type calcium channel blockers |